The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 23, 2016

Filed:

Dec. 23, 2011
Applicants:

Philippe Crine, Outremont, CA;

Simon Joubert, Montreal, CA;

Marie Parat, Montreal, CA;

Inventors:

Philippe Crine, Outremont, CA;

Simon Joubert, Montreal, CA;

Marie Parat, Montreal, CA;

Assignee:

Alexion Pharmaceuticals, Inc., Cheshire, CT (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 1/00 (2006.01); C07K 16/00 (2006.01); A61K 38/12 (2006.01); C07K 14/58 (2006.01); A61K 31/7088 (2006.01); A61K 38/22 (2006.01);
U.S. Cl.
CPC ...
C07K 14/58 (2013.01); A61K 31/7088 (2013.01); A61K 38/2242 (2013.01); C07K 2319/22 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01);
Abstract

The present invention provides methods, compositions, and kits for the treatment of disorders associated with overactivation of FGFR3, such as achondroplasia; bone or cartilage disorders; or vascular smooth muscle disorders, or for the elongation of bone. In some embodiments, the present invention provides polypeptides having a natriuretic peptide fused to an Fc domain of an immunoglobulin. Such polypeptides can be administered to subjects, e.g., subcutaneously, to treat a disorder associated with overactivation of FGFR3, a bone or cartilage disorder, or a vascular smooth muscle disorder, or to elongate bone. The invention also features nucleic acid molecules encoding such polypeptides and the use of the nucleic acid molecules for treating disorders associated with overactivation of FGFR3, bone or cartilage disorders, or vascular smooth muscle disorders, or for elongating bone.


Find Patent Forward Citations

Loading…